Our results demonstrate that deguelin inhibits the growth of NCSLC cells both in vitro and in vivo by down‐regulating Bmi1 expression and thus relieving Bmi1‐mediated Noxa repression, finally leading to NSCLC cells apoptosis. The gene discussed is BMI1; the disease is non-small cell lung carcinoma.